Sleep Apnea and Respiratory Monitoring Devices Market Size, Share & Trends Analysis Report By Product Type (Diagnostic Devices (Actigraphs, Polysomnography (PSG) devices, Respiratory Polygraphs, Pulse Oximeters), Therapeutic Devices (Positive Airway Pressure (PAP) Devices (CPAP, APAP, Bi-PAP), Oral Devices, Nasal Devices, Chin Straps), Sleep Apnea Masks), By End-Users, Region, And Segment Forecasts, 2025-2034

Global Sleep Apnea and Respiratory Monitoring Devices Market Size is valued at USD 6.1 Bn in 2021 and is predicted to reach USD 12.1 Bn by the year 2034 at a 7.2% CAGR during the forecast period for 2025-2034.

Key Industry Insights & Findings from the Report:

• The prevalence of other respiratory conditions, such as COPD and asthma, also drives the demand for respiratory monitoring devices. The need for continuous monitoring and management of these conditions supports market growth.
• Growing healthcare infrastructure and rising awareness in developing regions are opening new markets for sleep apnea and respiratory monitoring devices.
• North America dominated the market and accounted for a global revenue share in 2024.
• The process of gaining approval for medical devices can be protracted and rigorous, necessitating substantial effort and financial commitment from producers. This can result in a delay in the launch of new items and an increase in expenses.

Sleep apnea is a sleep disorder in which a person's breathing is interrupted during sleep. Two types of sleep apnea are obstructive sleep apnea and central sleep apnea. If sleep apnea is left untreated, it may lead to diabetes, High blood pressure, Headaches, depression, Heart failure, and stroke. Respiratory monitoring plays an essential role in treating respiratory diseases, such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), and asthma. Increasing demand for devices instead of surgeries will boost the sleep apnea and respiratory monitoring devices market growth over the forecast years.

High prevalence of sleep apnea and respiratory diseases, increasing geriatric population, changing lifestyle patterns, improper sleep patterns, and adoption of advanced technologies are driving the growth of this market. Moreover, rising awareness about sleep apnea and respiratory diseases is helping to enhance this business. Whereas, the high cost of systems, poor medical reimbursement policies, and shortage of skilled professionals are limiting the growth of this market.

Competitive Landscape

Some of The Key Players in The Sleep Apnea and Respiratory Monitoring Devices Market:

• DeVilbiss Healthcare LLC.
• Koninklijke Philips N.V.
• Medtronic plc
• Mindray
• Natus Medical Incorporated
• Nihon Kohden Corporation
• ResMed
• Smiths Medical
• SOMNOmedics America Inc.
• Itamar Medical Ltd.
• Cleveland Medical Devices, Inc.
• Compumedics Ltd.
• Fisher & Paykel Healthcare Limited
• Vyaire Medical, Inc.
• Becton, Dickinson and Company
• BMC Medical Co., Ltd.
• Other Prominent Players

Market Segmentation

The sleep apnea and respiratory monitoring devices market can be segmented on the basis of products, End-Use, and Regions. On the basis of products, the market can be sub-divided into diagnostic devices (actigraphs, polysomnography (PSG) devices, respiratory polygraphs, pulse oximeters), therapeutic devices (positive airway pressure (PAP) devices (CPAP, APAP, BI-PAP), oral devices, nasal devices, chin straps), sleep apnea masks. On the basis of end-users, the market is sub-segmented into hospitals & sleep laboratories, home care settings, and other end-use. The hospitals & Sleep Laboratories segment is expected to dominate this market, due to the increasing preference of patients to visit hospitals & sleep laboratories and the easy availability of necessary devices. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Out of these regions, North America is expected to dominate the market over the forecast period.

Recent Developments:

• In February 2021, ResMed announced that the San Diego-based company had introduced its AirCurve 11 series bilevel positive airway pressure devices in the United States. The AirCurve 11 series is the newest line of bilevel devices from ResMed that employs two degrees of support. They employ both expiratory and inspiratory positive airway pressure (EPAP and IPAP). AirCurve 11 was created to assist clinicians in treating sleep apnea while patients begin and continue therapy when combined with digital technologies.

The Sleep Apnea and Respiratory Monitoring Devices Market Report Scope

Global Sleep Apnea and Respiratory Monitoring Devices Market Segmentation

Sleep Apnea and Respiratory Monitoring Devices Market By Product Type-

• Diagnostic Devices
  • Actigraphs
  • Polysomnography (PSG) device
  • Respiratory Polygraphs
  • Pulse Oximeters
• Therapeutic Devices
  • Positive Airway Pressure (PAP) Devices
    • CPAP
    • APAP
    • Bi-PAP
  • Oral Devices
  • Nasal Devices
  • Chin Straps
• Sleep Apnea Masks

Sleep Apnea and Respiratory Monitoring Devices Market By End-Use-

• Hospitals & Sleep Laboratories
• Home Care Settings

Sleep Apnea and Respiratory Monitoring Devices Market By Region-

North America-

• The US
• Canada

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Mexico
• Rest of Latin America

 Middle East & Africa-

• GCC Countries
• South Africa
• Rest of the Middle East and Africa